Cellebrite DI (CLBT) Other Non-Current Liabilities (2020 - 2026)

Cellebrite DI has reported Other Non-Current Liabilities for 7 years, with the latest figure at $24.6 million in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 258.63% year-over-year to $24.6 million in Q2 2026; TTM through Jun 2026 was $24.6 million, a 258.63% increase from a year earlier, with the FY2025 full-year figure at $16.7 million, up 139.82% from the prior year.
• Other Non-Current Liabilities was $24.6 million for Q2 2026 at Cellebrite DI, up from $23.2 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $24.6 million in Q2 2026, with the low at $5.0 million in Q2 2023.
• Average Other Non-Current Liabilities over 5 years is $8.8 million, with a median of $6.5 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Other Non-Current Liabilities sank 43.44% in 2022, then surged 258.63% in 2026.
• Over 5 years, Other Non-Current Liabilities stood at $5.4 million in 2022, then climbed by 2.24% to $5.5 million in 2023, then grew by 26.09% to $7.0 million in 2024, then soared by 139.82% to $16.7 million in 2025, then soared by 47.35% to $24.6 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $24.6 million (Q2 2026), $23.2 million (Q1 2026), and $16.7 million (Q4 2025), per Business Quant data.